Impacts of vaccination on hepatitis B viral infections in Korea over a 25-year period

NH Park, YH Chung, HS Lee - Intervirology, 2010 - karger.com
Abstract Background: Hepatitis B virus (HBV) vaccination has effectively reduced the acute
and chronic infection rates in recent years. Since 1983, HBV vaccination has been …

[PDF][PDF] Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma

RJ Clifford, J Zhang, DM Meerzaman, MS Lyu… - …, 2010 - Wiley Online Library
Primary liver cancer is the third most common cause of cancer‐related death worldwide, with
a rising incidence in Western countries. Little is known about the genetic etiology of this …

Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: an observational cohort study

SB Lee, GM Park, JY Lee, BU Lee, JH Park, BG Kim… - Journal of …, 2018 - Elsevier
Background & Aims There are limited data on the association between non-alcoholic fatty
liver disease (NAFLD) and subclinical coronary atherosclerosis. This study investigated the …

A nationwide seroepidemiology of hepatitis C virus infection in South Korea

DY Kim, IH Kim, SH Jeong, YK Cho, JH Lee… - Liver …, 2013 - Wiley Online Library
Abstract Background & Aims The aim of this study was to reveal nationwide seroprevalence
of HCV infection in South Korea by a large‐scale survey. Methods From January to …

Topical application of capsaicin reduces visceral adipose fat by affecting adipokine levels in high‐fat diet‐induced obese mice

GR Lee, MK Shin, DJ Yoon, AR Kim, R Yu, NH Park… - …, 2013 - Wiley Online Library
Objective: Visceral obesity contributes to the development of obesity‐related disorders such
as diabetes, hyperlipidemia, and fatty liver disease, as well as cardiovascular diseases. In …

A genome-wide association study identified new variants associated with the risk of chronic hepatitis B

YJ Kim, HY Kim, JH Lee, SJ Yu, JH Yoon… - Human molecular …, 2013 - academic.oup.com
Hepatitis B virus (HBV) infection is the predominant risk factor for chronic hepatitis B (CHB),
liver cirrhosis (LC) and hepatocellular carcinoma (HCC). Recently, several genome-wide …

[HTML][HTML] Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir-vs. entecavir-based regimens: Individual patient data meta-analysis

WM Choi, TCF Yip, GLH Wong, WR Kim, LJ Yee… - Journal of …, 2023 - Elsevier
Background & Aims The comparative risk of hepatocellular carcinoma (HCC) in patients with
chronic hepatitis B (CHB) receiving tenofovir disoproxil fumarate (TDF) vs. entecavir (ETV) …

Korean Genome Project: 1094 Korean personal genomes with clinical information

S Jeon, Y Bhak, Y Choi, Y Jeon, S Kim, J Jang… - Science …, 2020 - science.org
We present the initial phase of the Korean Genome Project (Korea1K), including 1094 whole
genomes (sequenced at an average depth of 31×), along with data of 79 quantitative clinical …

Phase IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis B

CL Lai, SH Ahn, KS Lee, SH Um, M Cho, SK Yoon… - Gut, 2014 - gut.bmj.com
Background Besifovir (LB80380) is an acyclic nucleotide phosphonate effective in hepatitis
B virus (HBV) DNA suppression for both treatment-naive and lamivudine-resistant chronic …

Endoscopic enucleation for gastric subepithelial tumors originating in the muscularis propria layer

ID Jeong, SW Jung, SJ Bang, JW Shin, NH Park… - Surgical …, 2011 - Springer
Abstract Background Subepithelial tumors (SETs) of the stomach are considered benign.
However, they have the potential for malignant transformation, especially if they originate in …